Table 2 : Summary of efficacy parameters following 6 months co-therapies with sitagliptin.


Parameters Baseline 6 months T statistic (df) P value

Weight (kg) 73.56±16.474 73.39±16.372 0.595 (92) 0.553
BMI (kg/m2) 29.018±5.171 28.941±5.109 0.718 (92) 0.475
Systolic BP (mmHg)  135.31±17.876 138.25±21.280 -1.291 (92) 0.2
Diastolic BP (mmHg) 81.49±9.466 81.30±13.160 0.117 (92) 0.907
HDL (mmol/l) 1.234±0.255 1.176±0.248 3.493 (92) 0.001
LDL (mmol/l) 2.848±0.959 2.959±1.117 -1.006 (91) 0.317
Triglyceride (mmol/l) 1.758±1.166 1.904±1.521 -9.860 (92) 0.326
TC (mmol/l) 4.856±1.213 4.931±1.332 -0.597 (92) 0.552
FPG (mmol/l) 8.872±3.294 9.327±3.516 -1.080 (92) 0.283
HbA1C (%)  8.897±1.363  8.480±1.613  2.740 (92)  0.007

P value calculated using paired sample t test

Wan Bebakar et al.Journal of Diabetes Research and Clinical Metabolism  2014 3:10DOI : 10.7243/2050-0866-3-10